Please assess the completion status of the following clinical trial:

Trial Title: A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient is a survivor of acute lymphoblastic leukemia.~* Patient was treated on St. Jude Children's Research Hospital's Total XI, XII, or XIII treatment protocol.~* Patient is at least five years out from completion of therapy and is in first remission~Exclusion Criteria:~* Active disease~* Pregnant or lactating females~* Inability to chew and swallow pills~* Currently taking more than 800 mg supplemental calcium or 800 IU vitamin D~* Anemia

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1A (Type: PLACEBO_COMPARATOR): Nutritional counseling + placebo
- 1B (Type: EXPERIMENTAL): Nutritional counseling + supplementation with calcium, 1000mg/day + vitamin D, 800 units/day, for a 2 year period

Based on this trial design, predict the completion outcome and termination type (if applicable).